Plain-English translation of NCT06309225 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a gentler approach to treating oropharyngeal cancer in people age 65 and older. Instead of the standard high-dose chemotherapy and radiation regimen, participants receive cisplatin — a chemotherapy drug — once a week at a lower dose, combined with a slightly reduced course of radiation therapy over 5 weeks. The goal is to see if this adjusted approach works well while causing fewer side effects for older adults.
Older patients often struggle with the intensity of standard cancer treatment, experiencing severe side effects that can harm their quality of life and overall health. This trial exists to find out whether a modified, gentler version of this proven treatment can still effectively fight the cancer while being safer and more tolerable for seniors.
You likely qualify if…
You likely don't qualify if…
Over 5 weeks, you would receive radiation therapy once daily, 5 days a week at a treatment center. Once a week during those 5 weeks, you would also receive cisplatin chemotherapy by IV infusion, which may take 30 minutes to an hour, plus additional IV medications to help prevent side effects (adding another 2–4 hours at the clinic). You would need regular blood tests and follow-up visits to monitor your health and how well the treatment is working.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States